Breast Video Channel
Explore the latest insights and summaries from experts in Breast.
Recommended for You
Loading...
Trending Videos This Week
Loading...
Treatment Landscape
Nebraska Oncology Society
ASTRO Guidelines Updates for Partial Breast Irradiation: 4 Key Questions to Consider
FEATURING
Reshma Jagsi
- 109 views
- April 9, 2024
- 2
Nebraska Oncology Society
Early Stage TNBC Updates
FEATURING
Jairam Krishnamurthy
- 102 views
- April 9, 2024
- 1
Nebraska Oncology Society
Recent Advances in TNBC
FEATURING
Jairam Krishnamurthy
- 134 views
- April 9, 2024
- 1
Nebraska Oncology Society
Advances in Adjuvant RT for Localized BC: Radiation Treatment Considerations
FEATURING
Reshma Jagsi
- 69 views
- April 10, 2024
Nebraska Oncology Society
2024 Updates in mTNBC
FEATURING
Jairam Krishnamurthy
- 121 views
- April 10, 2024
- 1
London Breast Meeting
Updates in Systemic Therapy in mBC
FEATURING
Cornelia Leo
- 51 views
- April 16, 2024
- 1
London Breast Meeting
IO in Breast Cancer: Harnessing the Power of the Immune System
FEATURING
Alicia Okines
- 39 views
- April 16, 2024
London Breast Meeting
Treatment Options for Elderly and Multimorbid BC Patients
FEATURING
Cornelia Leo
- 59 views
- April 16, 2024
- 3
Cedars Sinai
2024 Updates in eBC Treatment for Postmenopausal HR+/HER2- Patients
FEATURING
Yuan Yuan
- 250 views
- April 18, 2024
- 2
University of Colorado Cancer Center
Optimal Treatment for Early Stage HER2+ BC: Tailoring Treatment to Response
FEATURING
Virginia Borges
- 346 views
- May 1, 2024
- 4
Lilly Medical Affairs
Progression on First-Line Therapy in HR+, HER2- MBC: Treatments and Sequencing
FEATURING
Joyce O’Shaughnessy
- 1,779 views
- July 24, 2024
- 10
Lilly Medical Affairs
CDK4/6 Inhibitors as First-Line Treatment for HR+, HER2- MBC
FEATURING
Joyce O’Shaughnessy
- 2,375 views
- July 24, 2024
- 12
Sara Tolaney
ASCO® 2024 Noteworthy Abstracts in Breast Cancer
FEATURING
Hope Rugo
- 932 views
- May 24, 2024
- 10
Insights from ESMO Breast 2024 Annual Meeting
ESMO Breast 2024 Summary: "Community Oncologists Highlights"
FEATURING
Sara Tolaney,
Hope Rugo
- 1,123 views
- May 24, 2024
- 11
Insights from ESMO Breast 2024 Annual Meeting
ESMO Breast 2024 Summary: "Rapid Insights"
FEATURING
Sara Tolaney,
Hope Rugo
- 59 views
- May 28, 2024
Insights from ESMO Breast 2024 Annual Meeting
Metastatic Breast Cancer Comprehensive Review: ESMO Breast 2024 Award Lecture
FEATURING
Hope Rugo
- 1,204 views
- June 7, 2024
- 10
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Breast Cancer Highlights - Monday Morning Practice
FEATURING
Sara Tolaney,
Hope Rugo
- 4,303 views
- June 7, 2024
- 30
Insights from ESMO Breast 2024 Annual Meeting
ESMO Breast 2024 Panel Discussion: "Key Updates in Breast Cancer"
FEATURING
Sara Tolaney,
Hope Rugo
- 941 views
- June 10, 2024
- 6
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Treatment and Outcomes in Select Subpopulations With Breast Cancer"
FEATURING
Lisa Carey
- 352 views
- June 18, 2024
- 2
Miami Cancer Institute Precision Oncology Symposium
Precision Therapy for HR+/HER2- mBC
FEATURING
Joyce O'Shaughnessy
- 517 views
- July 2, 2024
- 7
2024 ASCO® Annual Meeting Insights Hub
Management of Higher Risk eBC Including BRCAm, HER2- Subtypes
FEATURING
Milana Dolezal
- 363 views
- July 2, 2024
- 3
ecancer
ASCO® 2024: Highlights and Analysis of Key Solid Cancer Trials
FEATURING
Bishal Gyawali
- 105 views
- July 2, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Expert Recap: "Metastatic Breast Cancer Deep Dive & Clinical Implications"
FEATURING
Sara Tolaney,
Hope Rugo
- 929 views
- July 4, 2024
- 5
UChicago Medicine
Advances in Targeted and Endocrine Therapies for Metastatic HR+/HER2- Breast Cancer
FEATURING
Nan Chen
- 521 views
- July 11, 2024
- 3
UNC Lineberger Comprehensive Cancer Center
Updates in the Surgical Management for Breast Cancer
FEATURING
Kristalyn Gallagher
- 233 views
- July 19, 2024
- 5
ecancer
Best of ASCO®️ 2024: Adjuvant and Metastatic Indications of HR+ BC
FEATURING
Aurelio Castrellon
- 120 views
- August 2, 2024
- 1
Integrity CE
Clinical Roundtable: HR+ BC Early Stage & Metastatic Disease Updates
- 238 views
- August 2, 2024
- 1
Avan Armaghani
ASCO® 2024 Review: Treatment Updates on TNBC and HR+/HER2- Breast Cancer
- 279 views
- August 9, 2024
- 2
University of Illinois Cancer Center
Key Updates and Insights on HER2+ Breast Cancer
FEATURING
V.K. Gadi
- 175 views
- August 20, 2024
UChicago Medicine Annual Practice Updates in Hematology and Oncology
UChicago Medicine Updates in Early Stage BC
FEATURING
Frederick Howard
- 234 views
- August 26, 2024
UChicago Medicine Annual Practice Updates in Hematology and Oncology
UChicago Medicine Updates in mBC
FEATURING
Sudha Yarlagadda
- 76 views
- August 27, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO 2024 Highlights: Insights From Key Abstracts on mBC
FEATURING
Sramila Aithal
- 184 views
- August 27, 2024
- 2
Alessia Pellerino
Treatment Strategies for Leptomeningeal Disease in HER2+ mBC: Addressing Unmet Needs
- 163 views
- August 29, 2024
- 2
Katarzyna Jerzak
Advancements in Treatment Strategies for HR+/HER2- mBC: Current and Future Perspectives
- 178 views
- August 29, 2024
- 1
Sara Tolaney
ESMO 2024 Noteworthy Abstracts in Breast Cancer
FEATURING
Hope Rugo
- 557 views
- August 30, 2024
- 9
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: Hypo vs. Normofractionated RT in eBC - 5-Year Results of HypoG-01
FEATURING
Sofia Rivera
- 164 views
- September 20, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Breast Cancer Highlights - KEYNOTE-522, NATALEE, DESTINY-BREAST12, and CAPItello-290
FEATURING
Virginia Kaklamani
- 539 views
- September 23, 2024
- 7
RWJBarnabas Health Rutgers Cancer Institute of New Jersey
Evolution of Treatment Algorithms for HER2+ mBC
FEATURING
Mridula George
- 362 views
- September 26, 2024
- 3
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Management of Oligoprogressive Disease - Patients With Bone Metastases
FEATURING
Robbe Van den Begin
- 459 views
- September 26, 2024
- 7
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Highlights in mBC
FEATURING
Giampaolo Bianchini
- 532 views
- October 1, 2024
- 8
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: eBC Panel Discussion on Key Studies - KEYNOTE-522, I-SPY 2.2, and NATALEE
FEATURING
Sara Tolaney,
Hope Rugo
- 586 views
- October 4, 2024
- 5
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: mBC Panel Discussion on Key Studies - DESTINY-Breast12, CAPItello-290, and ICARUS-BREAST01
FEATURING
Sara Tolaney,
Hope Rugo
- 556 views
- October 4, 2024
- 7
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: T-DXd in HER2+ mBC With or Without Brain Metastases - DESTINYBreast-12 Primary Results
FEATURING
Nancy Lin
- 214 views
- October 8, 2024
- 1
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Tailoring Therapy in TNBC and Beyond
FEATURING
Lisa Carey
- 370 views
- October 8, 2024
- 5
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Systemic Treatment for ILCs in Breast Cancer
FEATURING
Jens Huober
- 342 views
- October 17, 2024
- 4
Yale Cancer Center
Key Trials and Updates in Breast Cancer: Expert Insights
FEATURING
Maryam Lustberg
- 193 views
- October 21, 2024
- 4
COR2ED The Heart of Medical Education
ESMO 2024 Summary: Breast Cancer Highlights - KEYNOTE-522, DESTINY-Breast12, and NATALEE
FEATURING
François-Clément Bidard
- 40 views
- October 25, 2024
Claudine Isaacs
mBC Updates: DESTINY-Breast06 Trial - 1L T-DXd vs. Chemo in HR+ HER2-Low & HER2-Ultralow Disease
- 230 views
- November 4, 2024
- 3
Total Health
Overview of Early Stage HER2+ BC Updates
FEATURING
Sonia Benn
- 45 views
- November 5, 2024
- 1
Total Health
Overview of Early Stage HR+/HER2- BC Updates
FEATURING
Sonia Benn
- 118 views
- November 5, 2024
- 1
Andrew Redfern
Something Old, New, or Borrowed: Optimizing 2L Therapy in HR+ HER2- mBC Post-CDK4/6 Inhibition
- 90 views
- November 15, 2024
- 3
Daniele Generali
Navigating Treatment Sequencing Post T-DXd Progression for HER2+ mBC
- 16 views
- November 15, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: Residual Cancer Burden & Adjuvant Capecitabine in Early TNBC With Non-pCR
FEATURING
Sung-Bae Kim
- 66 views
- November 15, 2024
- 1
University of Illinois Cancer Center
HR+/HER2- Early Breast Cancer: Risk Assessment and Treatment Updates
FEATURING
V.K. Gadi
- 201 views
- November 19, 2024
- 4
Icahn School of Medicine at Mount Sinai
De-Escalation of Systemic Therapy For Early Stage Breast Cancer
FEATURING
Amy Tiersten
- 135 views
- November 19, 2024
- 4
Sara Tolaney
SABCS 2024 Noteworthy Abstracts in Early Breast Cancer
FEATURING
Hope Rugo
- 613 views
- November 19, 2024
- 8
Sara Tolaney
SABCS 2024 Noteworthy Abstracts in Metastatic Breast Cancer
FEATURING
Hope Rugo
- 527 views
- November 19, 2024
- 6
Antonio Llombart Cussac
Integrating HER2-Low Targeted Therapies Into the Luminal mBC Treatment Landscape
- 133 views
- November 20, 2024
- 1
Yale Cancer Center
Breast Medical Oncology: A Multidisciplinary and Personalized Cancer Care Approach
FEATURING
Sarah Schellhorn Mougalian
- 36 views
- November 25, 2024
Nebraska Oncology Society
2024 Updates in Reconstructive Surgery for Breast Cancer
FEATURING
Marco Maricevich
- 18 views
- April 9, 2024
Nebraska Oncology Society
Advances in Adjuvant RT for Localized BC: Selective RT Omission After Breast-Conserving Surgery
FEATURING
Reshma Jagsi
- 91 views
- April 10, 2024
- 2
Kirollos Hanna
Integrating Oral Therapy for Patients With HR+/HER2- Early Stage BC
- 2,252 views
- July 19, 2024
- 5
RWJBarnabas Health Rutgers Cancer Institute of New Jersey
De-Escalation of Radiation in Breast Cancer: Finding the Optimal Balance
FEATURING
Bruce Haffty
- 34 views
- November 19, 2024
- 2
Margaret Gatti-Mays
Immunotherapy for TNBC: Remaining Questions and New Directions
- 149 views
- November 27, 2024
- 2
Nebraska Oncology Society
Advances in Adjuvant RT for Localized BC: Regional Nodal Irradiation
FEATURING
Reshma Jagsi
- 22 views
- April 10, 2024
ecancer
Choosing Wisely for Young Women With Breast Cancer: Radiotherapy
FEATURING
Tabassum Wadasadawala
- 19 views
- October 25, 2024
UChicago Medicine
Neoadjuvant & Adjuvant Therapy for High-Risk, Early Stage TNBC
FEATURING
Rita Nanda
- 255 views
- March 1, 2024
- 5
UChicago Medicine
Neoadjuvant & Adjuvant Therapy for HER2+, High-Risk, Early Stage BC
FEATURING
Rita Nanda
- 289 views
- March 1, 2024
- 1
UChicago Medicine
2024 Neoadjuvant IO Updates for HR+ BC
FEATURING
Gini Fleming
- 120 views
- March 1, 2024
- 1
UChicago Medicine
2024 (Neo)Adjuvant Systemic Therapy Updates for HR+ BC
FEATURING
Gini Fleming
- 516 views
- March 1, 2024
- 4
Dana-Farber Cancer Institute
Older Adults With Breast Cancer: Research Updates
FEATURING
Rachel Freedman
- 221 views
- March 1, 2024
- 1
Total Health
Neoadjuvant ET for HR+ BC: Year in Review
FEATURING
Cynthia Ma
- 200 views
- March 2, 2024
- 3
Total Health
Neoadjuvant Chemo for HR+ BC: Year in Review
FEATURING
Cynthia Ma
- 983 views
- March 2, 2024
- 5
Insights from 2023 SABCS
SABCS 2023 Insights: "Optimizing Adjuvant Endocrine Therapy for Premenopausal Women"
FEATURING
Vered Stearns
- 461 views
- March 2, 2024
- 2
UChicago Medicine
Advanced HR+ BC: Elacestrant vs. ET, Alpelisib/Inavolisib for PIK3CAm Tumors, Capivasertib for AKT Pathway-Altered Tumors
FEATURING
Nan Chen
- 222 views
- March 4, 2024
- 1
UChicago Medicine
2024 Updates on ADCs in HER2-Low, HR+, and TNBC
FEATURING
Hope Rugo
- 201 views
- March 4, 2024
- 3
Total Health
Advances in Early Stage TNBC: Post-Neoadjuvant Therapy
FEATURING
Melinda Telli
- 130 views
- March 7, 2024
- 4
Total Health
Advances in Early Stage TNBC: IO Progress and Future Direction
FEATURING
Melinda Telli
- 38 views
- March 7, 2024
Total Health
Advances in Early Stage TNBC: Treatment Progress
FEATURING
Melinda Telli
- 137 views
- March 7, 2024
- 2
Total Health
Current Adjuvant Treatment in BRCA+ BC
FEATURING
Gregory Vidal
- 82 views
- March 12, 2024
- 1
Total Health
Current Adjuvant Treatment in HR+ BC
FEATURING
Gregory Vidal
- 156 views
- March 12, 2024
- 2
Total Health
Current Adjuvant Treatment in HER2+ BC
FEATURING
Gregory Vidal
- 252 views
- March 12, 2024
- 1
Total Health
Antibody Drug Conjugates: Highlights in Breast Cancer
FEATURING
Kevin Kalinsky
- 315 views
- March 12, 2024
- 1
Total Health
Advanced Stage HR+ BC: Fine-Tuning Sequential Endocrine and Targeted Therapy in the 2L Setting
FEATURING
Ruth O'Regan
- 450 views
- March 12, 2024
- 2
Total Health
Advanced Stage HR+ BC: Fine-Tuning Sequential Endocrine and Targeted Therapy in the 1L Setting
FEATURING
Ruth O'Regan
- 1,369 views
- March 12, 2024
- 4
Scripps Health
CDK4/6 Inhibitor Therapy in Early-Stage HR+/HER2- BC
FEATURING
Sarah Sammons
- 1,750 views
- March 19, 2024
- 10
Scripps Health
2024 Neuro-Oncology Update: Breast Cancer and Brain Mets
FEATURING
Tresa McGranahan
- 368 views
- April 2, 2024
- 3
Yale Cancer Center
Breast Cancer Updates: The Role of Surgery After Neoadjuvant Systemic Therapy
FEATURING
Charles Balch
- 154 views
- April 3, 2024
- 1
Nebraska Oncology Society
Axillary Management Considerations After Neoadjuvant Chemotherapy for Breast Cancer
FEATURING
Olga Kantor
- 16 views
- April 10, 2024
Nebraska Oncology Society
Omission of SLNB in Early Stage BC
FEATURING
Olga Kantor
- 15 views
- April 10, 2024
London Breast Meeting
Lymphedema Preventative Strategies
FEATURING
Ketan Patel
- 13 views
- April 16, 2024
London Breast Meeting
What's on the Horizon? Breast Reconstruction With Perforator Flaps
FEATURING
Koenraad Van Landuyt
- 73 views
- April 16, 2024
- 1
Lilly Medical Affairs
Communicating the Risk of Recurrence for Patients With HR+, HER2- Early Breast Cancer
FEATURING
Joyce O’Shaughnessy
- 475 views
- October 23, 2024
- 2
Bruce Haffty
Omitting PMRT or Nodal RT in Breast Cancer After Node Conversion: NRG B51 Insights
- 96 views
- August 9, 2024
- 2
Sheldon Feldman
New Approaches to Decrease the Risk of Breast Cancer-Related Lymphedema
- 65 views
- August 27, 2024
- 1
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: A Registry-Based Study of pCR & Survival After Neoadjuvant Chemo in Stage I TNBC
FEATURING
Manon De Graaf
- 46 views
- October 1, 2024
- 1
Kathryn Post
Perspectives on the Effects of Time Toxicity in Breast Cancer Treatment
FEATURING
Jennifer Hutchinson
- 627 views
- October 3, 2024
- 3
Yale Cancer Center
Axillary Management: To Dissect or Not to Dissect
FEATURING
Ellie Proussaloglou
- 33 views
- October 21, 2024
Yale Cancer Center
Radiation Therapy for Breast Cancer: Basics, Historical Perspectives, and Recent Advances
FEATURING
Meena Moran
- 16 views
- November 25, 2024
Yale Cancer Center
Reconstruction Options After Breast Cancer
FEATURING
Siba Haykal
- 25 views
- November 25, 2024
Yale Cancer Center
Breast Reconstruction: Options and Approaches
FEATURING
Paris Butler
- 27 views
- November 25, 2024
University of Illinois Cancer Center
Key Updates in Metastatic HER2+++ Breast Cancer
FEATURING
V.K. Gadi
- 14 views
- December 6, 2024
University of Illinois Cancer Center
Optimizing Treatment Sequencing for Metastatic TNBC
FEATURING
V.K. Gadi
- 4 views
- December 6, 2024
University of Illinois Cancer Center
Metastatic HR+/HER2- BC: CDK4/6 Inhibitor Insights and Next-Line Treatment Options
FEATURING
V.K. Gadi
- 44 views
- December 6, 2024
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: EmpowHER 303 - Zanidatamab vs. Trastuzumab + Chemo in HER2+ mBC Post-T-DXd
FEATURING
Sara Tolaney
- 2 views
- December 17, 2024
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: Updates on Next-Generation PI3K Inhibitors for Advanced Breast Cancer
FEATURING
Christos Vaklavas
- 80 views
- December 17, 2024
- 4
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: Addressing Pathologic and Therapeutic Challenges in Lobular Breast Cancer
FEATURING
Laszlo Tabar
- 40 views
- December 17, 2024
- 3
Therapeutic Agents
Nebraska Oncology Society
Early Stage TNBC Updates
FEATURING
Jairam Krishnamurthy
- 102 views
- April 9, 2024
- 1
Nebraska Oncology Society
2024 Updates in mTNBC
FEATURING
Jairam Krishnamurthy
- 121 views
- April 10, 2024
- 1
London Breast Meeting
Updates in Systemic Therapy in mBC
FEATURING
Cornelia Leo
- 51 views
- April 16, 2024
- 1
London Breast Meeting
IO in Breast Cancer: Harnessing the Power of the Immune System
FEATURING
Alicia Okines
- 39 views
- April 16, 2024
Cedars Sinai
Management of Toxicities Associated With Targeted Agents in Stage 4 HR+/HER2- BC
FEATURING
Yuan Yuan
- 275 views
- April 18, 2024
- 2
Cedars Sinai
Unmet Need in HR+/HER2- mBC: Resistance to 1L CDK4/6i and ET
FEATURING
Yuan Yuan
- 420 views
- April 18, 2024
- 2
ecancer
KEYNOTE-756 Trial - Adding Pembro to Chemo Before and After BC Surgery
FEATURING
Javier Cortes
- 341 views
- April 23, 2024
- 2
MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis
Successes and Challenges of Early Drug Development for Brain Metastasis
FEATURING
Alex Drilon
- 302 views
- April 30, 2024
- 2
MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis
Breast Cancer Brain Metastases: From a Medical Oncologist’s Perspective
FEATURING
Rebecca Dent
- 344 views
- April 30, 2024
- 4
MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis
Frontiers in Breast Cancer Brain Metastasis: ADC Effectiveness in the CNS
FEATURING
Shanu Modi
- 285 views
- April 30, 2024
- 3
University of Colorado Cancer Center
Optimal Treatment for Early Stage HER2+ BC: Tailoring Treatment to Response
FEATURING
Virginia Borges
- 346 views
- May 1, 2024
- 4
Lilly Medical Affairs
SERDS: Relevance and Role in Current & Future Treatments for HR+, HER2- MBC
FEATURING
Komal Jhaveri
- 746 views
- July 24, 2024
- 7
Lilly Medical Affairs
CDK4/6 Inhibitors as First-Line Treatment for HR+, HER2- MBC
FEATURING
Joyce O’Shaughnessy
- 2,375 views
- July 24, 2024
- 12
Sara Tolaney
ASCO® 2024 Noteworthy Abstracts in Breast Cancer
FEATURING
Hope Rugo
- 932 views
- May 24, 2024
- 10
Insights from ESMO Breast 2024 Annual Meeting
ESMO Breast 2024 Summary: "Community Oncologists Highlights"
FEATURING
Sara Tolaney,
Hope Rugo
- 1,123 views
- May 24, 2024
- 11
Insights from ESMO Breast 2024 Annual Meeting
ESMO Breast 2024 Summary: "Rapid Insights"
FEATURING
Sara Tolaney,
Hope Rugo
- 59 views
- May 28, 2024
University of Illinois Cancer Center
Clinical Guidance on the Management and Monitoring of T-DXd-Related Adverse Events in HER2+ mBC
FEATURING
V.K. Gadi
- 303 views
- May 28, 2024
- 3
COR2ED The Heart of Medical Education
54 y/o Postmenopausal Woman ER+ mBC Case Discussion: Elacestrant and Beyond
FEATURING
Maria Vittoria Dieci
- 82 views
- June 4, 2024
COR2ED The Heart of Medical Education
Treating ER+/HER2-Low mBC: 2L and Beyond
FEATURING
Aditya Bardia
- 247 views
- June 4, 2024
- 5
Insights from ESMO Breast 2024 Annual Meeting
Metastatic Breast Cancer Comprehensive Review: ESMO Breast 2024 Award Lecture
FEATURING
Hope Rugo
- 1,204 views
- June 7, 2024
- 10
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "ACE-Breast-02 Trial - ARX788 vs. Lapatinib + Capecitabine in HER2+ ABC"
FEATURING
Xi-Chun Hu
- 49 views
- June 12, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "H3B-6545 in Women With ER+/HER2- mBC"
FEATURING
Erika Hamilton
- 27 views
- June 18, 2024
ecancer
ASCO® 2024 Insights: "I-SPY2.2 Trial - Pathologic Response to Neoadjuvant Datopotamab Deruxtecan in Breast Cancer"
FEATURING
Jane Meisel
- 235 views
- June 20, 2024
Miami Cancer Institute Precision Oncology Symposium
Incorporating IO and Emerging Therapeutic Strategies for mTNBC
FEATURING
Reshma L. Mahtani
- 148 views
- July 2, 2024
Miami Cancer Institute Precision Oncology Symposium
HER2 Targeted Treatments in Lower BC Expression Ranges
FEATURING
Ian Krop
- 225 views
- July 2, 2024
- 2
Miami Cancer Institute Precision Oncology Symposium
Precision Therapy for HR+/HER2- mBC
FEATURING
Joyce O'Shaughnessy
- 517 views
- July 2, 2024
- 7
Mattea Reinisch
Real-World Management of Patients With mTNBC Receiving Sacituzumab Govitecan
- 221 views
- July 4, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Expert Recap: "Metastatic Breast Cancer Deep Dive & Clinical Implications"
FEATURING
Sara Tolaney,
Hope Rugo
- 929 views
- July 4, 2024
- 5
UChicago Medicine
Advances in Targeted and Endocrine Therapies for Metastatic HR+/HER2- Breast Cancer
FEATURING
Nan Chen
- 521 views
- July 11, 2024
- 3
Integrity CE
Clinical Roundtable: HR+ BC Early Stage & Metastatic Disease Updates
- 238 views
- August 2, 2024
- 1
Avan Armaghani
ASCO® 2024 Review: Treatment Updates on TNBC and HR+/HER2- Breast Cancer
- 279 views
- August 9, 2024
- 2
Adrienne Waks
New Insights Into Optimizing HER2-Directed Therapy in the Curative Setting
- 202 views
- August 13, 2024
- 2
Seth Wander
Serial CDK4/6 Inhibitor Therapy for HR+-HER2- MBC: Evolving Insights, Key Questions, and Ongoing Studies
- 536 views
- August 13, 2024
- 5
University of Illinois Cancer Center
Key Updates and Insights on HER2+ Breast Cancer
FEATURING
V.K. Gadi
- 175 views
- August 20, 2024
UChicago Medicine Annual Practice Updates in Hematology and Oncology
UChicago Medicine Updates in mBC
FEATURING
Sudha Yarlagadda
- 76 views
- August 27, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO 2024 Highlights: Insights From Key Abstracts on mBC
FEATURING
Sramila Aithal
- 184 views
- August 27, 2024
- 2
Alessia Pellerino
Treatment Strategies for Leptomeningeal Disease in HER2+ mBC: Addressing Unmet Needs
- 163 views
- August 29, 2024
- 2
Katarzyna Jerzak
Advancements in Treatment Strategies for HR+/HER2- mBC: Current and Future Perspectives
- 178 views
- August 29, 2024
- 1
Stanford Medicine
Hot Flashes: Nonhormonal Options for Cancer Patients
FEATURING
Milana Dolezal
- 305 views
- September 18, 2024
- 5
Houston Methodist
Early Interception in Breast Cancer: Organ Preservation and Avoidance of Systemic Side Effect
FEATURING
Pamela Munster
- 21 views
- September 18, 2024
Patrick Neven
Patient Selection for Adjuvant Abemaciclib in HR+/HER2- eBC
- 188 views
- September 19, 2024
- 1
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: PROMENADE Trial - Pembro for Early ER-Low/HER2- BC - Real World French Cohort
FEATURING
Francois Cherifi
- 89 views
- September 23, 2024
- 2
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: Pembro or Placebo + CT in High-Risk Early TNBC - OS Results From KEYNOTE-522
FEATURING
Heather McArthur
- 157 views
- September 24, 2024
- 3
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: CAPItello-290 Trial - Capivasertib + Paclitaxel as 1L Treatment for mTNBC
FEATURING
Heather McArthur
- 140 views
- September 24, 2024
- 1
Miguel Abreu
monarchE Study: The Impact of Dose Reductions on Abemaciclib Efficacy in High-Risk eBC
- 383 views
- September 26, 2024
- 3
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: IBI354 - Anti-HER2 ADC in Advanced Solid Tumors and Breast Cancer
FEATURING
Christina Teng
- 76 views
- October 1, 2024
- 2
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: T-DXd in HER2+ mBC With or Without Brain Metastases - DESTINYBreast-12 Primary Results
FEATURING
Nancy Lin
- 214 views
- October 8, 2024
- 1
Priya Tiwari
Benefits of Oral Formulations in HR+/HER2- mBC: Reducing Time Toxicity and Improving Well-Being
- 488 views
- October 9, 2024
- 2
ecancer
ESMO 2024 Insights: Neo-CheckRay Trial - Durvalumab & Oleclumab Boost for SBRT + Chemo in ER+/HER2- eBC
FEATURING
Alex De Caluwe
- 16 views
- October 11, 2024
ecancer
ESMO 2024 Insights: WSG-TP-II Trial - ET + Trastuzumab & Pertuzumab vs. De-Escalated Chemo + Trastuzumab & Pertuzumab in HR+/HER2+ eBC
FEATURING
Oleg Gluz
- 43 views
- October 11, 2024
- 1
Fernanda Mosele
Trastuzumab Deruxtecan's Efficacy Across HER2 Expression Levels in mBC: Key Results From the DAISY Trial
- 370 views
- October 16, 2024
- 3
Jan-Willem Henning
NATALEE Trial Impact on eBC: Ribociclib + ET as Adjuvant Treatment in Patients With HR+/HER2- Disease
- 484 views
- October 21, 2024
- 5
Yale Cancer Center
Key Trials and Updates in Breast Cancer: Expert Insights
FEATURING
Maryam Lustberg
- 193 views
- October 21, 2024
- 4
Jan-Willem Henning
monarchE Trial & High-Risk eBC: Efficacy, Safety, QoL, and Biomarker Analysis
- 127 views
- October 22, 2024
Claudine Isaacs
mBC Updates: DESTINY-Breast06 Trial - 1L T-DXd vs. Chemo in HR+ HER2-Low & HER2-Ultralow Disease
- 230 views
- November 4, 2024
- 3
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: TroFuse-010 Trial - Sacituzumab Tirumotecan ± Pembro vs. Chemo in HR+/HER2- Advanced BC
FEATURING
Sara Tolaney
- 262 views
- November 4, 2024
- 2
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: Adjuvant Ribociclib + NSAI in HR+/HER2- eBC - 4-Year Outcomes From the NATALEE Trial
FEATURING
Peter Fasching
- 70 views
- November 19, 2024
- 1
Sara Tolaney
SABCS 2024 Noteworthy Abstracts in Metastatic Breast Cancer
FEATURING
Hope Rugo
- 527 views
- November 19, 2024
- 6
Antonio Llombart Cussac
Integrating HER2-Low Targeted Therapies Into the Luminal mBC Treatment Landscape
- 133 views
- November 20, 2024
- 1
Junji Tsurutani
Impact of T-Dxd Approval on HER2-Low mBC Treatment and Patient Outcomes
- 140 views
- November 25, 2024
- 2
Kirollos Hanna
Integrating Oral Therapy for Patients With HR+/HER2- Early Stage BC
- 2,252 views
- July 19, 2024
- 5
Yale Cancer Center
Innovations in Breast Medical Oncology: Immunotherapy in eBC
FEATURING
Kathleen Fenn
- 27 views
- November 13, 2024
UChicago Medicine
Neoadjuvant & Adjuvant Therapy for High-Risk, Early Stage TNBC
FEATURING
Rita Nanda
- 255 views
- March 1, 2024
- 5
UChicago Medicine
Neoadjuvant & Adjuvant Therapy for HER2+, High-Risk, Early Stage BC
FEATURING
Rita Nanda
- 289 views
- March 1, 2024
- 1
UChicago Medicine
2024 Neoadjuvant IO Updates for HR+ BC
FEATURING
Gini Fleming
- 120 views
- March 1, 2024
- 1
Total Health
Immune Checkpoint Inhibitors and Neoadjuvant Chemo for HR+ BC: Year in Review
FEATURING
Cynthia Ma
- 235 views
- March 2, 2024
UChicago Medicine
Advanced ER+ BC: Novel Endocrine Agents Such as ER PROTACs and ER CERANs With Promising Early Phase Data
FEATURING
Nan Chen
- 103 views
- March 4, 2024
- 2
UChicago Medicine
Advanced HR+ BC: Elacestrant vs. ET, Alpelisib/Inavolisib for PIK3CAm Tumors, Capivasertib for AKT Pathway-Altered Tumors
FEATURING
Nan Chen
- 222 views
- March 4, 2024
- 1
UChicago Medicine
New and Emerging CDK4/6i Therapies for Advanced HR+ BC
FEATURING
Nan Chen
- 329 views
- March 4, 2024
- 6
UChicago Medicine
ADCs in Breast Cancer: Ongoing Trials and Future Directions
FEATURING
Hope Rugo
- 48 views
- March 4, 2024
UChicago Medicine
2024 Updates on ADCs in HER2-Low, HR+, and TNBC
FEATURING
Hope Rugo
- 201 views
- March 4, 2024
- 3
UChicago Medicine
Antibody Drug Conjugates: Overview and Background of a Revolution in Breast Cancer Treatment
FEATURING
Hope Rugo
- 541 views
- March 4, 2024
- 4
University of Louisville
Role of m6A in RNA Transcripts in Endocrine-Therapy Resistance in Breast Cancer Cells
FEATURING
Carolyn Klinge
- 13 views
- March 12, 2024
Total Health
Current Adjuvant Treatment in HR+ BC
FEATURING
Gregory Vidal
- 156 views
- March 12, 2024
- 2
Total Health
Current Adjuvant Treatment in HER2+ BC
FEATURING
Gregory Vidal
- 252 views
- March 12, 2024
- 1
Total Health
ADCs in Breast Cancer: Datopotamab Deruxtecan Overview
FEATURING
Heather McArthur
- 173 views
- March 12, 2024
- 3
Total Health
ADCs in Breast Cancer: Sacituzumab Govitecan Overview
FEATURING
Heather McArthur
- 147 views
- March 12, 2024
- 1
Total Health
ADCs in Breast Cancer: Trastuzumab Emtansine Overview
FEATURING
Heather McArthur
- 21 views
- March 12, 2024
Total Health
Antibody Drug Conjugates: Future Applications in Breast Cancer
FEATURING
Kevin Kalinsky
- 234 views
- March 12, 2024
- 3
Total Health
Antibody Drug Conjugates: Highlights in Breast Cancer
FEATURING
Kevin Kalinsky
- 315 views
- March 12, 2024
- 1
Total Health
Advanced Stage HR+ BC: Fine-Tuning Sequential Endocrine and Targeted Therapy in the 2L Setting
FEATURING
Ruth O'Regan
- 450 views
- March 12, 2024
- 2
Total Health
Advanced Stage HR+ BC: Fine-Tuning Sequential Endocrine and Targeted Therapy in the 1L Setting
FEATURING
Ruth O'Regan
- 1,369 views
- March 12, 2024
- 4
Masonic Cancer Center, University of Minnesota
Lobular Carcinoma of the Breast: MDC1 & Gene Regulations
FEATURING
Matthew Sikora
- 10 views
- March 15, 2024
Scripps Health
CDK4/6 Inhibitor Therapy in Early-Stage HR+/HER2- BC
FEATURING
Sarah Sammons
- 1,750 views
- March 19, 2024
- 10
Scripps Health
Anthracyclines for Early Stage Breast Cancer - Do They Still Have a Role?
FEATURING
Virginia Borges
- 1,347 views
- March 19, 2024
- 18
Integrity CE
TROP-2 ADCs for the Treatment of HR+/HER2- BC, TNBC, and NSCLC: Advancing Care in the Community Oncology Setting
FEATURING
Lee Schwartzberg,
Jason Porter
- 125 views
- March 20, 2024
- 1
Scripps Health
2024 Neuro-Oncology Update: Breast Cancer and Brain Mets
FEATURING
Tresa McGranahan
- 368 views
- April 2, 2024
- 3
London Breast Meeting
How to Avoid Lower Pole Stretch
FEATURING
Patrick Mallucci
- 28 views
- April 16, 2024
London Breast Meeting
How to Avoid Implant Lateralization and Casualization in an Unstable Implant
FEATURING
Charles Randquist
- 48 views
- April 16, 2024
MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis
Chemoprevention in Brain Mets: Breast Cancer Perspective
FEATURING
Alexandra Zimmer
- 263 views
- April 30, 2024
- 7
University of Colorado Cancer Center
Type 2 Diabetes Risk With Endocrine Therapies for Breast Cancer
FEATURING
Rebecca Scalzo
- 18 views
- May 9, 2024
Total Health
The Role of Radiation Therapy in Oncology
FEATURING
Ryan Lanning
- 116 views
- July 1, 2024
Stanford Medicine
Sexual Health and Wellbeing in Women’s Cancer Survivors
FEATURING
Milana Dolezal
- 217 views
- July 10, 2024
- 4
Cleveland Clinic Taussig Cancer Institute
Options for Breast Neurotization: How I Do It
FEATURING
Ziv Peled
- 39 views
- September 3, 2024
Cleveland Clinic Taussig Cancer Institute
Bone Health in Premenopausal Women With Early BC Receiving ET
FEATURING
Sabashini Ramchand
- 131 views
- September 6, 2024
- 3
Cleveland Clinic Taussig Cancer Institute
Endocrine Therapy in Young Women With Early BC
FEATURING
Erin Roesch
- 201 views
- September 6, 2024
- 4
Houston Methodist
Post Cryoablation Pathological Findings
FEATURING
Mary Schwartz
- 4 views
- October 8, 2024
Houston Methodist
Cryoablation for Breast Cancer: The Basics
FEATURING
Luz Venta
- 77 views
- October 8, 2024
- 1
Houston Methodist
Cryoablation - The Big Picture
FEATURING
Davood Abdollahian
- 133 views
- October 14, 2024
Houston Methodist
Cryoablation: Abscopal Effect & Immune Therapy
FEATURING
Robert Ward
- 8 views
- October 14, 2024
Yale Cancer Center
Identifying and Targeting DNA Repair Mutations in Cancer
FEATURING
Shridar Ganesan
- 30 views
- October 14, 2024
Yale Cancer Center
Radiation Therapy in Breast Cancer Treatment
FEATURING
Susan Higgins
- 13 views
- November 25, 2024
University of Illinois Cancer Center
ADC Therapy for Metastatic HR+/HER2- BC
FEATURING
V.K. Gadi
- 4 views
- December 6, 2024
University of Illinois Cancer Center
Metastatic HR+/HER2- BC: CDK4/6 Inhibitor Insights and Next-Line Treatment Options
FEATURING
V.K. Gadi
- 44 views
- December 6, 2024
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: EmpowHER 303 - Zanidatamab vs. Trastuzumab + Chemo in HER2+ mBC Post-T-DXd
FEATURING
Sara Tolaney
- 2 views
- December 17, 2024
Diagnostics & Biomarkers
Houston Methodist
Review and Updates of New and Upcoming Cytopathology Reporting Systems: 2024
FEATURING
Elizabeth M. Jacobi
- 10 views
- April 4, 2024
Nebraska Oncology Society
Optimizing Use of Axillary Ultrasound to Select Patients for Neoadjuvant BC Therapy
FEATURING
Olga Kantor
- 14 views
- April 10, 2024
London Breast Meeting
Updates in Systemic Therapy in mBC
FEATURING
Cornelia Leo
- 51 views
- April 16, 2024
- 1
London Breast Meeting
Intra-Operative Confirmation of Margins in Breast Conserving Surgery
FEATURING
Ashutosh Kothari
- 33 views
- April 16, 2024
- 1
MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis
State-of-the-Art Imaging for Brain Metastasis
FEATURING
Benjamin Ellingson
- 124 views
- April 30, 2024
- 1
University of Colorado Cancer Center
Young Women With HR+/HER2- Breast Cancer: Options for Risk Assessment
FEATURING
Virginia Borges
- 428 views
- May 1, 2024
- 3
Weill Cornell Medicine Oncology & Hematology
Inflammatory Breast Cancer - Diagnosis and Management Updates
FEATURING
Massimo Cristofanilli
- 497 views
- May 15, 2024
- 4
UChicago Medicine 12th International Clinical Cancer Genomics Conference
The Promise of Multi-Cancer Detection Assays
FEATURING
Peter Kuhn
- 103 views
- May 21, 2024
- 2
Lilly Medical Affairs
Resistance Mechanisms to ET, Including ESR1 Mutations in HR+, HER2- MBC
FEATURING
Komal Jhaveri
- 930 views
- July 24, 2024
- 4
Lilly Medical Affairs
Progression on First-Line Therapy in HR+, HER2- MBC: Treatments and Sequencing
FEATURING
Joyce O’Shaughnessy
- 1,779 views
- July 24, 2024
- 10
COR2ED The Heart of Medical Education
Treating ER+/HER2-Low mBC: 2L and Beyond
FEATURING
Aditya Bardia
- 247 views
- June 4, 2024
- 5
2024 ASCO® Annual Meeting Insights Hub
Development and Validation of RSClinN+ Tool for HR+/HER2- Node-Positive BC
FEATURING
Lajos Pusztai
- 835 views
- June 17, 2024
- 5
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Elucidating the Immune Active State of HR+/HER2- MammaPrint High 2 Early BC"
FEATURING
Erin Cobain
- 356 views
- June 18, 2024
- 3
ecancer
ASCO® 2024 Insights: "Clinical Behavior and Prognostic Impact of Genetic Testing in Young BRCA Breast Cancer Patients"
FEATURING
Matteo Lambertini
- 83 views
- July 2, 2024
- 1
Miami Cancer Institute Precision Oncology Symposium
Precision Therapy for HR+/HER2- mBC
FEATURING
Joyce O'Shaughnessy
- 517 views
- July 2, 2024
- 7
Fred Hutchinson Cancer Center
Biology and Clinical Relevance of ESR1 Mutation in Breast Cancer
FEATURING
Nancy Davidson
- 248 views
- August 2, 2024
- 2
Lajos Pusztai
Evaluating PCR as an Endpoint for Approving New Therapies in eBC
- 164 views
- August 9, 2024
- 2
Aurelio Castrellon
Prognostic Roles of AMH and ctDNA Detection in HR+/HER2- Node+ eBC
- 213 views
- August 20, 2024
- 4
Weill Cornell Medicine Oncology & Hematology
Defining High-Risk HR+/HER2- eBC: Clinical Pearls for Oncologists
FEATURING
Eleonora Nicolò
- 173 views
- August 22, 2024
- 1
UChicago Medicine Annual Practice Updates in Hematology and Oncology
UChicago Medicine Updates in Early Stage BC
FEATURING
Frederick Howard
- 234 views
- August 26, 2024
Han-Byoel Lee
Identifying Breast Cancer Subtypes and Recurrence Risk: Multigene Assays in Treatment Decisions
- 321 views
- August 27, 2024
- 3
UChicago Medicine
Racial Disparities in Breast Cancer Screening and Diagnosis
FEATURING
Nan Chen
- 113 views
- August 29, 2024
Alessia Pellerino
Treatment Strategies for Leptomeningeal Disease in HER2+ mBC: Addressing Unmet Needs
- 163 views
- August 29, 2024
- 2
Cleveland Clinic Taussig Cancer Institute
Breast Imaging and the Young Patient
FEATURING
Laura Dean
- 204 views
- September 3, 2024
- 7
Cleveland Clinic Taussig Cancer Institute
Evaluation of a Polygenic Risk Score as a Predictor of Early Onset TNBC in Black Women
FEATURING
Holly Pederson
- 18 views
- September 11, 2024
Cleveland Clinic Taussig Cancer Institute
Genomic Landscape of Young and Older Onset Breast Cancer
FEATURING
Shimoli Barot
- 87 views
- September 11, 2024
Adam Brufsky
Brief Update on Genomic Assays for Early Stage Breast Cancer
- 448 views
- September 11, 2024
- 4
Houston Methodist
Novel Approaches in Oncology: Early Interception & BRCA Advances in Breast & Ovarian Cancer Therapy
FEATURING
Pamela Munster
- 28 views
- September 18, 2024
Oncology Data Advisor
AI Advancing Breast Cancer Detection: Insights From iCAD
FEATURING
Waqas Haque,
Dana Brown
- 19 views
- September 18, 2024
Shabnam Jaffer
The 2023 ASCO®/CAP Guideline Update on HER2 Testing/Classification: Best Practices
- 738 views
- September 23, 2024
- 2
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: ctDNA and Molecular Screening for Target Detection and Treatment Monitoring in mBC
FEATURING
Michail Ignatiadis
- 144 views
- September 26, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Highlights in mBC
FEATURING
Giampaolo Bianchini
- 532 views
- October 1, 2024
- 8
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: Quantitative High Sensitivity HER2 Testing With Trastuzumab Deruxtecan in mBC
FEATURING
Paolo Tarantino
- 257 views
- October 1, 2024
- 4
Yale Cancer Center
Evaluating the Effectiveness of New Technologies in Breast Cancer Screening
FEATURING
Ilana Richman
- 38 views
- October 1, 2024
COR2ED The Heart of Medical Education
The Evolving Role of Liquid Biopsy With a Focus on NSCLC, BC, and CRC
FEATURING
Umberto Malapelle
- 280 views
- October 1, 2024
- 3
Houston Methodist
Interventional Breast Imaging: US, Stereo & MRI
FEATURING
Luz Venta
- 62 views
- October 8, 2024
- 2
Yale Cancer Center
Unraveling the Genetic Tapestry: Advances in Germline Testing
FEATURING
Veda Giri
- 22 views
- October 16, 2024
Fernanda Mosele
Trastuzumab Deruxtecan's Efficacy Across HER2 Expression Levels in mBC: Key Results From the DAISY Trial
- 370 views
- October 16, 2024
- 3
ecancer
ESMO 2024 Insights: ROME Basket Trial - Targeting Actionable Mutations vs. SoC in Pts With Advanced Solid Tumors
FEATURING
Andrea Botticelli
- 15 views
- October 22, 2024
Yale Cancer Center
HER2 Ultra-Low: Is It Real? A Close Look at Companion Diagnostics for Trastuzumab Deruxtecan (T-DXd) in Breast Cancer
FEATURING
David Rimm
- 118 views
- October 25, 2024
ecancer
Surveillance Imaging in Solid Tumors: More Complicated Than It Appears
FEATURING
Christopher Booth
- 234 views
- October 25, 2024
- 3
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: Long-Term Outcomes and Treatment Strategies by ER Expression in Breast Cancer
FEATURING
Kazuki Nozawa
- 113 views
- October 29, 2024
Springer Healthcare IME
New Frontiers in Oncology: Advanced Diagnostics and Therapeutics
FEATURING
Solange Peters
- 177 views
- October 29, 2024
- 3
UCI Health
Advancing Breast Cancer Care With Liquid Biopsy Biomarkers
FEATURING
Ritesh Parajuli
- 5 views
- November 4, 2024
Sherry Yang
TAILORx Trial: Endocrine Therapy, 21-Gene Recurrence Score, and Clinical Outcomes in eBC
- 174 views
- November 20, 2024
- 1
Houston Methodist
BRCA2 Mutations and Hereditary Cancer Risk
FEATURING
Pamela Munster
- 63 views
- September 18, 2024
- 1
Cleveland Clinic Taussig Cancer Institute
Counseling Women With a Genetic Predisposition to Breast Cancer
FEATURING
Claudine Isaacs
- 49 views
- September 3, 2024
Yale Cancer Center
Individualizing Adjuvant Therapy for HR+/HER2- eBC
FEATURING
Anca Bulgaru
- 44 views
- November 25, 2024
- 1
UChicago Medicine
2024 Neoadjuvant IO Updates for HR+ BC
FEATURING
Gini Fleming
- 120 views
- March 1, 2024
- 1
Total Health
56 y/o Post-Menopausal Female With ER 90%, PR 70%, HER2-Neu Denovo mBC: Case Panel Discussion
- 113 views
- March 1, 2024
- 1
Total Health
Neoadjuvant ET for HR+ BC: Year in Review
FEATURING
Cynthia Ma
- 200 views
- March 2, 2024
- 3
Total Health
Cardio-Oncology in Breast Cancer: Treatment Options for Immune Checkpoint Inhibitors
FEATURING
Isaac Rhea
- 62 views
- March 6, 2024
- 1
Total Health
Cardio-Oncology in Breast Cancer: Treatment Options for Anthracyclines & HER2
FEATURING
Isaac Rhea
- 108 views
- March 6, 2024
- 1
Total Health
General Approach to Cardio-Oncology in Breast Cancer
FEATURING
Isaac Rhea
- 23 views
- March 6, 2024
GRACE
Early Diagnosis of Breast Cancer: Importance and Statistics
FEATURING
Doug Micalizzi
- 16 views
- April 2, 2024
Dana-Farber Cancer Institute
Concepts of Treatment, Progression, and Staging in mBC
FEATURING
Sarah Sammons
- 39 views
- April 2, 2024
UNC Lineberger Comprehensive Cancer Center
The Importance of Molecular Testing in HR+/HER2- mBC
FEATURING
Yara Abdou
- 373 views
- April 2, 2024
- 5
Nebraska Oncology Society
Optimizing Axillary Staging in Upfront Breast Cancer Surgery
FEATURING
Olga Kantor
- 46 views
- April 10, 2024
London Breast Meeting
Minimizing Morbidity in Axillary Lymph Node Dissection
FEATURING
Gemma Pons
- 32 views
- April 16, 2024
Everardo Saad
Surrogate Endpoints: Demystifying Their Role in Breast Cancer Research
- 22 views
- December 2, 2024
University of Illinois Cancer Center
Genetic Testing Insights: PRS, Germline Variant Detection, and Clonal Hematopoiesis
FEATURING
Kent Hoskins
- 10 views
- December 12, 2024
Disease Overview
University of Colorado Cancer Center
Early Stage BC Clinical Overview: Grading, Staging, and Treatment Options
FEATURING
Virginia Borges
- 610 views
- May 1, 2024
- 8
University of Colorado Cancer Center
Early Stage BC Clinical Overview: Understanding Risk Factors
FEATURING
Virginia Borges
- 42 views
- May 1, 2024
- 1
Lilly Medical Affairs
A Heterogenous Disease with Varied Clinical Outcomes: HR+/HER2- MBC
FEATURING
Joyce O’Shaughnessy
- 1,454 views
- July 24, 2024
- 8
Lilly Medical Affairs
Unmet Needs for Patients With HR+, HER2- Early Breast Cancer at a High Risk of Recurrence
FEATURING
Hope Rugo
- 400 views
- October 23, 2024
- 3
Tiffany Onger
Unequal Outcomes: Disparities in Breast Cancer for Black Women
- 132 views
- August 29, 2024
- 3
Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course
Therapy for Non-Invasive BC & Prevention
FEATURING
Rachel Yung
- 126 views
- July 24, 2024
- 4
Dana-Farber Cancer Institute
Sexual Health and Sexual Recovery for Adults Living With mBC
FEATURING
Sharon Bober
- 22 views
- March 4, 2024
Total Health
Cardiac Disease in Breast Cancer: Background & Risk Factors
FEATURING
Isaac Rhea
- 95 views
- March 6, 2024
- 1
Total Health
Advances in Early Stage TNBC: Historical Perspective
FEATURING
Melinda Telli
- 107 views
- March 7, 2024
- 1
Masonic Cancer Center, University of Minnesota
Lobular Carcinoma of the Breast: MDC1 Interactome
FEATURING
Matthew Sikora
- 15 views
- March 15, 2024
Masonic Cancer Center, University of Minnesota
Lobular Carcinoma of the Breast: ERα Signaling in Breast & Gynecological Cancers
FEATURING
Matthew Sikora
- 27 views
- March 15, 2024
UCLA Health
The Obesity-Cancer Link: Current Hypotheses for Causal Connection
FEATURING
Vijaya Surampudi
- 183 views
- March 26, 2024
- 5
London Breast Meeting
The Ruptured Breast Implant: Timelines for Surgery
FEATURING
John Ys Kim
- 60 views
- April 16, 2024
- 2
MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis
Type I IFN Response in Brain Metastasis
FEATURING
Qingrong Chen
- 74 views
- April 30, 2024
- 1
University of Colorado Cancer Center
Understanding Immune Fitness and Age to Improve Breast Cancer Outcomes
FEATURING
Sandra Mcallister
- 16 views
- May 9, 2024
UChicago Medicine 12th International Clinical Cancer Genomics Conference
Management of Breast Cancer Patients With BRCA1/2 Mutation
FEATURING
Steven Narod
- 212 views
- May 26, 2024
- 2
Total Health
Breast Cancer Surgery and Subsequent Care
FEATURING
Katrina Oyague
- 85 views
- July 2, 2024
Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course
Radiation Oncology: Basic Principles and Updates in 2024
FEATURING
Jonathan Chen
- 200 views
- July 18, 2024
- 3
Lilly Medical Affairs
Supporting Patients With Breast Cancer in the Clinic: Setting the Patient Up for Success
FEATURING
Shaheenah Dawood
- 182 views
- October 23, 2024
- 1
Masonic Cancer Center, University of Minnesota
Sleepwalking Through Evolution: A Tale of Dormancy and Hormone Dependent Breast Cancer
FEATURING
Luca Magnani
- 115 views
- August 2, 2024
Cleveland Clinic Taussig Cancer Institute
Sensory Outcomes After Neurotization for Nipple-Sparing Mastectomy
FEATURING
Anne Peled
- 39 views
- September 3, 2024
- 1
Cleveland Clinic Taussig Cancer Institute
Exercise, Weight Loss, and Breast Cancer Risk: The Importance of BMI
FEATURING
Amy Guthrie
- 107 views
- September 3, 2024
- 4
Cleveland Clinic Taussig Cancer Institute
Sexual Health & Contraception in Young Women With Breast Cancer
FEATURING
Anna Chichura
- 37 views
- September 3, 2024
Cleveland Clinic Taussig Cancer Institute
Fertility Preservation for Breast Cancer: Clinical Considerations & Future Directions
FEATURING
Mindy Christianson
- 50 views
- September 3, 2024
- 1
Cleveland Clinic Taussig Cancer Institute
Management of Breast Cancer During Pregnancy
FEATURING
Erica Mayer
- 184 views
- September 11, 2024
- 3
Cleveland Clinic Taussig Cancer Institute
Radiation for Young Women With Breast Implants or Oncoplastic Surgery
FEATURING
Chirag Shah
- 45 views
- September 11, 2024
- 1
Oncology Data Advisor
Managing Chemotherapy-Induced Neuropathy in Breast Cancer: Research Highlights and Survivor Experiences
FEATURING
Megan-Claire Chase,
Constance Visovsky
- 11 views
- September 18, 2024
ecancer
Choosing Wisely for Young Women With Breast Cancer: Medical Therapy
FEATURING
Shriniwas Subhash Kulkarni
- 54 views
- October 25, 2024
- 1
ecancer
Choosing Wisely for Young Women With Breast Cancer: Surgery
FEATURING
Shalaka Joshi
- 11 views
- October 25, 2024
ecancer
Choosing Wisely for Young Women With Breast Cancer: Balco Medical Centre Data
FEATURING
Siddharth Turkar
- 9 views
- October 25, 2024
Yale Cancer Center
The Reconstructive Journey in Breast Cancer
FEATURING
Kamal Addagatla
- 16 views
- November 13, 2024
Yale Cancer Center
Radiation Therapy in Breast Cancer: Personalized Patient Care and De-escalation of Treatment
FEATURING
Kevin Du
- 22 views
- November 13, 2024
- 1
Yale Cancer Center
Breast Cancer Update: Risk Based Screening, Genetics and Prevention
FEATURING
Melanie Lynch
- 33 views
- November 13, 2024
Yale Cancer Center
Surgical Care of Breast Cancer
FEATURING
Ellie Proussaloglou
- 26 views
- November 25, 2024
Case Studies
Nebraska Oncology Society
Updates in Breast Cancer Surgery: Oncoplastic Reconstruction After Lumpectomy
FEATURING
Marco Maricevich
- 40 views
- April 9, 2024
Nebraska Oncology Society
mTNBC Selection, Sequencing, and Treatment Paradigm With Case Examples
FEATURING
Jairam Krishnamurthy
- 38 views
- April 10, 2024
London Breast Meeting
My Free Flap Failed: Now What? Algorithm for Breast Reconstruction Management
FEATURING
Christoph Andree
- 32 views
- April 16, 2024
London Breast Meeting
Nipple Sparing Mastectomy and Reconstruction in the Large or Ptotic Breast
FEATURING
Maurice Nahabedian
- 78 views
- April 16, 2024
COR2ED The Heart of Medical Education
Oral SERDS: New ET Options in ER+ mBC - Case Review
FEATURING
Valentina Guarneri
- 146 views
- April 18, 2024
MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis
ER+ mBC Patient That Underwent Bilateral Mastectomy and Developed Brain Mets: Multidisciplinary Tumor Board Case Discussion
FEATURING
Adrienne Boire,
Joshua Budhu,
Brandon Imber,
Nelson Moss,
Andrew Seidman,
Robert Young,
Mark Kris
- 156 views
- May 4, 2024
COR2ED The Heart of Medical Education
54 y/o Postmenopausal Woman ER+ mBC Case Discussion: Elacestrant and Beyond
FEATURING
Maria Vittoria Dieci
- 82 views
- June 4, 2024
Northwell Health
The Management of HER2+ eBC: Case Discussion and Recent Updates
FEATURING
Francisco Esteva
- 276 views
- June 18, 2024
- 1
Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course
Managing Metastatic Breast Cancer: Case Study Insights
FEATURING
Natasha Hunter
- 378 views
- July 24, 2024
- 5
Cleveland Clinic Taussig Cancer Institute
Mental Health and the Young Breast Cancer Survivor
FEATURING
Kathleen Ashton
- 25 views
- September 11, 2024
Houston Methodist
Interventional Breast Imaging: US, Stereo & MRI
FEATURING
Luz Venta
- 62 views
- October 8, 2024
- 2
Yale Cancer Center
Case Discussions and Advances in TNBC Management and Treatment Strategies
FEATURING
Andrea Silber,
Adriana Kahn
- 21 views
- October 21, 2024
ecancer
Surveillance Imaging in Solid Tumors: More Complicated Than It Appears
FEATURING
Christopher Booth
- 234 views
- October 25, 2024
- 3
Yale Cancer Center
Optimizing Therapy for ER+/PR+/HER2+ Breast Cancer: Ultra-Hypofractionation
FEATURING
Suzanne Evans
- 23 views
- November 7, 2024
Houston Methodist
Stereotactic Guidance for Cryoablation
FEATURING
Modupe Adeyefa
- 5 views
- October 8, 2024
London Breast Meeting
Working Toward Breast Reconstruction as a Day Case: An Evaluation of ERAS Protocols
FEATURING
Alanna Rebecca
- 10 views
- April 16, 2024
Houston Methodist
Cryoablation: The Memorial Sloan Kettering Experience
FEATURING
Yolanda Bryce
- 159 views
- October 14, 2024
- 3
Total Health
56 y/o Post-Menopausal Female With ER 90%, PR 70%, HER2-Neu Denovo mBC: Case Panel Discussion
- 113 views
- March 1, 2024
- 1
University of Colorado Department of Medicine
Cardiotoxicity in Breast Cancer – Case Discussion
FEATURING
Lavanya Kondapalli
- 192 views
- March 7, 2024
- 1
Total Health
62 y/o Woman With mBC and Liver Lesions: Case Presentation and Panel Discussion
- 112 views
- March 15, 2024
- 1
Total Health
55 y/o With mBC (Lung and Bone Disease): Case Presentation and Panel Discussion
- 49 views
- March 15, 2024
- 1
Total Health
56 y/o Post-Menopausal Woman With T2N+ Grade III IDC: Case Presentation and Panel Discussion
- 84 views
- March 15, 2024
- 1
Total Health
62 y/o With HER2+ mBC Who Underwent 2L TDXd Therapy: Case Presentation and Panel Discussion
- 454 views
- March 15, 2024
Total Health
52 y/o With T2N0 Grade III TNBC: Case Presentation and Panel Discussion
- 449 views
- March 15, 2024
- 1
Total Health
52 y/o With HER2+ De Novo mBC: Case Presentation and Panel Discussion
- 269 views
- March 15, 2024
- 1
UCLA Health
A Case of Osteoporosis in a Breast Cancer Survivor
FEATURING
Mopelola Adeyemo,
Dave Garg
- 48 views
- March 26, 2024
Nebraska Oncology Society
Updates in Breast Cancer Surgery: Mastectomy
FEATURING
Marco Maricevich
- 70 views
- April 9, 2024
London Breast Meeting
Correction of Partial Breast Deformities With Free Flaps
FEATURING
Ara Salibian
- 25 views
- April 16, 2024
London Breast Meeting
Autologous Reconstruction in the Flap Cripple: When to Say "No"
FEATURING
Stefania Tuinder
- 33 views
- April 16, 2024
